BARCLAYS PLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 98 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2019$10,000
-95.4%
34,472
-26.6%
0.00%
Q1 2019$217,000
+933.3%
46,971
+668.5%
0.00%
Q4 2018$21,000
-97.2%
6,112
-91.8%
0.00%
Q3 2018$747,000
-6.9%
74,101
-33.2%
0.00%
-100.0%
Q2 2018$802,000
+16.7%
110,881
-2.3%
0.00%
Q1 2018$687,000
-36.7%
113,487
+0.6%
0.00%
Q4 2017$1,086,000
+2162.5%
112,764
+1994.0%
0.00%
Q3 2017$48,000
-44.8%
5,385
-21.2%
0.00%
Q2 2017$87,000
-60.5%
6,832
-67.5%
0.00%
Q1 2017$220,000
+16.4%
21,027
+2.9%
0.00%
Q4 2016$189,000
+490.6%
20,443
+654.6%
0.00%
Q3 2016$32,000
-60.5%
2,709
-49.6%
0.00%
Q1 2016$81,000
+189.3%
5,377
+413.1%
0.00%
Q4 2015$28,000
-99.9%
1,048
-99.9%
0.00%
-100.0%
Q3 2015$21,815,000
-9.2%
779,153
+13.5%
0.03%
-3.7%
Q2 2015$24,017,000
+55753.5%
686,190
+91636.6%
0.03%
Q1 2015$43,000
-40.3%
748
-56.3%
0.00%
Q4 2014$72,000
-52.9%
1,711
-57.5%
0.00%
Q3 2014$153,000
-38.8%
4,025
-50.1%
0.00%
Q2 2014$250,000
+4.6%
8,064
+38.4%
0.00%
Q1 2014$239,000
+210.4%
5,825
+183.6%
0.00%
Q4 2013$77,000
+1183.3%
2,054
+992.6%
0.00%
Q3 2013$6,000
+50.0%
188
-29.1%
0.00%
Q2 2013$4,0002650.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2019
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders